• Latest Posts

Six synthetic biology companies that have made a mark

ADC firm Adcentrx Therapeutics aims for clinic after $38M boost

Podcast 28 Apr 2023

Beyond Biotech podcast 43

Australian biopharma Telix banks on AI with Dedicaid acquisition

Vedanta Biosciences raises $106.5M for microbiome therapy

Patients with asthma and other inflammatory lung diseases can be treated ‘in a fundamentally new way’

ADVERTISEMENT

Biogen ALS drug gets FDA ok

LincRNA discovery could lead to targeted treatments

Progress in battle against stomach cancer

In Depth 26 Apr 2023

Vaccine for honeybees: a new hope for American foulbrood disease

aVaxziPen’s needle-free vaccine yields positive data across multiple diseases

Global partners announce The Big Catch-up vaccination effort

ADVERTISEMENT